PTJ
NVAX icon

Paul Tudor Jones’s Novavax NVAX Stock Holding History

Paul Tudor Jones’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
125,468
-3,391
-3% -$30.4K ﹤0.01% 2296
2026
Q1 		$1.05M Buy
+128,859
New +$1.17M ﹤0.01% 2334
2024
Q2 		– Sell
-37,030
Closed -$177K – 2646
2024
Q1 		$177K Buy
+37,030
New +$172K ﹤0.01% 2058
2023
Q3 		– Sell
-12,289
Closed -$91.3K – 2685
2023
Q2 		$91.3K Buy
+12,289
New +$96.6K ﹤0.01% 2299
2023
Q1 		– Sell
-46,624
Closed -$479K – 2795
2022
Q4 		$479K Buy
46,624
+7,694
+20% +$136K 0.01% 1609
2022
Q3 		$709K Sell
38,930
-27,221
-41% -$1.18M 0.02% 1160
2022
Q2 		$3.4M Buy
66,151
+18,886
+40% +$978K 0.09% 289
2022
Q1 		$3.48M Buy
47,265
+43,374
+1,115% +$3.87M 0.08% 314
2021
Q4 		$557K Sell
3,891
-5,218
-57% -$897K 0.01% 1382
2021
Q3 		$1.89M Sell
9,109
-324
-3% -$71.4K 0.03% 751
2021
Q2 		$2M Buy
+9,433
New +$1.73M 0.04% 563
2018
Q3 		– Sell
-869
Closed -$23K – 1197
2018
Q2 		$23K Buy
+869
New +$29.4K ﹤0.01% 1013
2017
Q2 		– Sell
-871
Closed -$22K – 1270
2017
Q1 		$22K Sell
871
-1,176
-57% -$32.3K ﹤0.01% 1344
2016
Q4 		$52K Sell
2,047
-3,703
-64% -$108K ﹤0.01% 1335
2016
Q3 		$239K Buy
+5,750
New +$742K 0.01% 1157
2015
Q4 		– Sell
-1,749
Closed -$247K – 1777
2015
Q3 		$247K Buy
1,749
+541
+45% +$121K 0.01% 1221
2015
Q2 		$269K Sell
1,208
-11,621
-91% -$2.04M 0.01% 1169
2015
Q1 		$2.12M Buy
+12,829
New +$2.08M 0.07% 157
2014
Q3 		– Sell
-15,000
Closed -$1.39M – 1454
2014
Q2 		$1.39M Buy
15,000
+13,503
+902% +$1.19M 0.05% 147
2014
Q1 		$136K Buy
1,497
+150
+11% +$16.8K 0.01% 1095
2013
Q4 		$138K Buy
+1,347
New +$95.2K 0.01% 1169

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Paul Tudor Jones's NVAX Position: Q2 2026 in Review

Paul Tudor Jones reduced its Novavax (NVAX) stake by 2.6% in Q2 2026, selling an estimated $30.4K and leaving 125,468 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Paul Tudor Jones first reported a position in NVAX in Q4 2013 and has held it in 21 quarters since. The position peaked at $3.48M in Q1 2022. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Paul Tudor Jones held 125,468 shares of Novavax worth $1.18M as of Q2 2026.
  • Paul Tudor Jones sold 3,391 Novavax shares in Q2 2026, an estimated $30.4K.
  • Novavax made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2296 holding.
  • Paul Tudor Jones first reported a position in Novavax in Q4 2013 and has held it in 21 quarters since.
  • Paul Tudor Jones's Novavax position peaked at $3.48M in Q1 2022.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.